Brief: Active Biotech Q3 loss narrows

Active Biotech AB publ

14/11/2016 06:20

Nov 14 (Reuters) - Active Biotech Ab  ACTI.ST  
    * Active biotech AB interim report January - September 2016 
    * Q3 net sales SEK 4.1 million (5.2 mln) 
    * Q3 operating loss SEK 11.1 million (loss of 22.2 mln) 
    * Cash and cash equivalents at the end of the period SEK 
39.9 million  
 
 
Source text for Eikon:  ID:nGNEbBd1MB  
Further company coverage:  ACTI.ST  
 
 (Reporting by Stockholm Newsroom) 
 ((stockholm.newsroom@thomsonreuters.com; +46-(0)8-700 10 17;))